Department of Surgery, Amsterdam University Medical Centres, University of Amsterdam, Meibergdreef 9, Post Box 22660, 1100 DD, Amsterdam, The Netherlands.
LEXOR, Centre for Experimental and Molecular Medicine, Oncode Institute, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Tech Coloproctol. 2019 Aug;23(8):751-759. doi: 10.1007/s10151-019-02055-1. Epub 2019 Aug 20.
Abdominoperineal resection (APR) carries a high risk of perineal wound morbidity. Perineal wound closure using autologous tissue flaps has been shown to be advantageous, but there is no consensus as to the optimal method. The aim of this study was to evaluate the feasibility of a novel gluteal turnover flap (GT-flap) without donor site scar for perineal closure after APR.
Consecutive patients who underwent APR for primary or recurrent rectal cancer were included in a prospective non-randomised pilot study in two academic centres. Perineal reconstruction consisted of a unilateral subcutaneous GT-flap, followed by midline closure. Feasibility was defined as uncomplicated perineal wound healing at 30 days in at least five patients, and a maximum of two flap failures.
Out of 17 potentially eligible patients, 10 patients underwent APR with GT-flap-assisted perineal wound closure. Seven patients had pre-operative radiotherapy. Median-added theatre time was 38 min (range 35-44 min). Two patients developed a superficial perineal wound dehiscence, most likely because of the excessive width of the skin island. Two other patients developed purulent discharge and excessive serosanguinous discharge, respectively, resulting in four complicated wounds at 30 days. No flap failure occurred, and no radiological or surgical reinterventions were performed. Median length of hospital stay was 10 days (IQR 8-12 days).
The GT-flap for routine perineal wound closure after APR seems feasible with limited additional theatre time, but success seems to depend on correct planning of the width of the flap. The potential for reducing perineal morbidity should be evaluated in a randomised controlled trial.
腹会阴联合切除术(APR)会导致很高的会阴伤口发病率。使用自体组织皮瓣关闭会阴伤口已被证明是有利的,但对于最佳方法尚无共识。本研究旨在评估一种新型臀侧翻转皮瓣(GT-皮瓣)在 APR 后用于会阴关闭的可行性,该皮瓣无需供区瘢痕。
在两个学术中心,连续纳入接受原发性或复发性直肠癌 APR 的患者进行前瞻性非随机试点研究。会阴重建包括单侧皮下 GT-皮瓣,然后行中线关闭。可行性定义为至少 5 例患者在 30 天内无并发症的会阴伤口愈合,且皮瓣失败的数量最多为 2 例。
在 17 例有潜在入选可能的患者中,有 10 例患者接受了 APR 手术,并采用 GT-皮瓣辅助会阴伤口关闭。7 例患者术前接受了放疗。中位附加手术室时间为 38 分钟(范围 35-44 分钟)。2 例患者出现会阴浅层伤口裂开,最有可能是因为皮岛的宽度过大。另外 2 例患者分别出现脓性和过多浆液血性分泌物,导致 30 天时出现 4 例复杂伤口。没有皮瓣失败,也没有进行影像学或手术再次干预。中位住院时间为 10 天(IQR 8-12 天)。
对于 APR 后常规会阴伤口关闭,GT-皮瓣似乎是可行的,附加手术室时间有限,但成功似乎取决于皮瓣宽度的正确规划。应在随机对照试验中评估降低会阴发病率的潜力。